FAP and meningioma: FAP and SSTR2a expression (present vs. absent) were not associated with overall survival (p > 0.05).<h4>Conclusion</h4>SSTR2a and FAP are expressed in high-grade meningioma samples to a variable extent, and differences across meningioma subtypes underscore the need for biomarkers to improve patient selection.